TWO SIGMA ADVISERS, LP - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 127 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$8,181,675
-63.8%
229,500
-53.2%
0.02%
-63.8%
Q2 2023$22,626,765
+13.3%
490,500
-1.5%
0.06%
+13.7%
Q1 2023$19,965,790
-6.5%
497,900
+8.1%
0.05%
-15.0%
Q4 2022$21,344,231
+903.0%
460,700
+796.3%
0.06%
+900.0%
Q3 2022$2,128,000
-66.0%
51,400
-25.9%
0.01%
-62.5%
Q3 2021$6,259,000
-52.4%
69,400
-49.7%
0.02%
-54.3%
Q2 2021$13,149,000
-12.6%
137,900
+4.4%
0.04%
-14.6%
Q1 2021$15,041,000
+82.0%
132,100
+121.3%
0.04%
+86.4%
Q4 2020$8,264,000
+168.8%
59,700
+59.6%
0.02%
+144.4%
Q3 2020$3,074,0000.0%37,400
-4.8%
0.01%0.0%
Q2 2020$3,074,000
-70.1%
39,300
-57.1%
0.01%
-85.2%
Q4 2015$10,274,000
-33.3%
91,586
-42.2%
0.06%
-37.1%
Q3 2015$15,398,000
+176.4%
158,400
+191.2%
0.10%
+125.6%
Q2 2015$5,570,000
+2084.3%
54,400
+1226.8%
0.04%
+2050.0%
Q1 2015$255,000
-54.1%
4,100
-58.2%
0.00%
-50.0%
Q3 2014$555,0009,8000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2015
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 519,119$40,605,0003.00%
First Light Asset Management, LLC 236,958$18,535,0002.16%
SECTOR GAMMA AS 108,734$8,505,0001.76%
Rock Springs Capital Management LP 646,841$50,596,0001.39%
Atika Capital Management LLC 79,000$6,180,0000.80%
Capital Impact Advisors, LLC 30,582$2,392,0000.80%
FEDERATED HERMES, INC. 4,080,359$319,166,0000.79%
Rhenman & Partners Asset Management AB 61,500$4,811,0000.52%
Ikarian Capital, LLC 73,500$5,749,0000.46%
Capital International, Inc./CA/ 477,858$37,378,0000.46%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders